Apply knowledge of drug resistance mechanisms beyond EGFR, including MET and HER2 amplifications, to guide the effective use of targeted therapies in EGFR-mutant NSCLC
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
AMA PRA Category 1 Credit™Up to 0.75 credits
MOC types
No MOC
FDA REMS
No
Qualifies for MIPS
No
Target Specialties
Address:
- 124 S. Franklin Street
Pricing
89% of listed courses are free
25 of 28 courses listed here are free.
Collected from the provider’s public pages · source
Specialties served/covered
- Allergy & Clinical Immunology
- Anatomic & Clinical Pathology
- Cardiothoracic Surgery
- Critical Care Medicine
- Endocrinology, Diabetes & Metabolism
- Gastroenterology
- Gastrointestinal Surgery
- General Surgery
- Gynecologic Oncology
- Head & Neck Surgery
- Hematology
- Medical Genetics & Genomics
- Medical Oncology
- Neurology
- Neuromuscular Medicine
- Obstetrics & Gynecology
- Ophthalmology
- Orthopaedic Surgery
- Orthopaedic Trauma
- Pulmonary Disease
- Surgical Critical Care
- Surgical Oncology
- Thoracic Surgery
- Cardio-Vascular
- Emergency & Critical Care
- ENT & Head Neck
- GI & Liver
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Orthopedics
- Pathology & Lab
- Surgery
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Online course / module
- Credit · Up to 0.75 credits
- Commercial Support
-
ReleasedOct 20, 2025
-
Last day to claim creditJan 16, 2027 3 months left
-
Answers in CME Inc. (AiCME) Beyond the Biomarker: Bridging Patient Voices and Precision Care in HER2-Mutant NSCLC
-
University of Chicago School of Medicine Strategies for Improving ERBB2 (HER2) Testing in NSCLC Within Community Settings
-
LUNGevity Foundation +1 Mastering the Breakthroughs in HER2-Mutant NSCLC: Decoding Alterations, Refining Treatment, and Empowering Patients
